A Community of Rambunctious Scholars Celebrating People
Who Have Made Lifesaving Discoveries And Encouraging
Students and Politicians to Read 1000 Science Stories!

TOTAL LIVES SAVED
Max Theiler

How fast can you count to this #?

We Need Your Help!

Do You Know This Scientist?

If you do, we welcome your input.  Please share your funny stories, brief anecdotes, quotes, and photos of the scientist - as well as your own inspirational opinions.  Personal accounts help bring a scientist alive and create an enduring historical picture.  You can be a part of this exciting history by providing your personal account! 

Please click here to learn more about how to contribute:
Participate as a Friend Scholar

Can You Write or Research?

Help us learn more about this great scientist.  You can be a credited Support Scholar by contributing your knowledge about this scientist and important discovery.  Entries can be as short as a single section and as easy as compiling quotes.  Click here to learn more about becoming a Support Scholar:
Participate as a Support Scholar

Would you like to adopt a scientist?

Endeavor to research all the sections of a scientist. Click here to learn how to be an Expert Scholar.
Participate as an Expert Scholar

Have Historically Significant Photographs?
Participate with Photos

Click here for all the ways you can participate:
Participate to ScienceHeroes.com

Testimonials

Has this scientist’s science impacted your life?
Click here to tell your story or to read others’ life changing anecdotes:
Post Your Own Testimonial


Max Theiler
(January 30, 1899 - August 11, 1972)
Born in South Africa
Year of Discovery: 1931
readitIntroAbove
theiler_wiki_prob_fair_use_
His Vaccine Had Stunning Success Against Yellow Fever

Sometimes a little frustration is a good thing. Theiler (pronounced Tyler) began his career with an earnest desire to see more being done. He felt there was a lack of cures for many serious illnesses and that many existing treatments were simply ineffective. After receiving his medical degree in London, he accepted a position at Harvard and began researching a variety of diseases, including amoebic dysentery and rat bite fever. But, returning to an illness he had first explored in England, Theiler soon turned his full attention to yellow fever. This was no small commitment, as researchers were at great risk of contracting the potentially fatal disease. In fact, Adrian Stokes, the scientist who first isolated the virus with which Theiler worked, was among those who died from yellow fever. Theiler's first major discovery was a way to use mice as test subjects for yellow fever. Prior to his work, researchers had had to rely on monkeys as hosts, which was both costly and dangerous. Theiler worked tirelessly to develop a vaccine to fight against yellow fever. It was his discovery that led, through a series of refinements, to the development of a vaccine suitable for mass production.

Yellow fever is a potentially fatal viral disease transmitted to humans through the bite of an infected mosquito. Human to human transmission does not occur, but infected individuals can still carry the disease to other regions through a process known as peridomestic transmission, in which an infected person first passes the disease to a mosquito, which then transfers it to another person. There is an incubation period of three to six days following infection, during which a person shows no symptoms. The person then enters the first phase of yellow fever, which include flu-lke symptoms such as high fever, chills, muscle pain, headache, and nausea. These symptoms subside after three to four days and the patient feels better. However, this is often just the "eye of the hurricane," and about 15 percent of patients enter a second, more serious "toxic phase" within 24 hours. The patient quickly develops jaundice, a yellowing of the skin caused by liver complications. Severe abdominal pain and vomiting follow. The patient may begin to bleed from the mouth, nose, and eyes. Internal bleeding may also occur, and blood may show up in the patient's vomit and feces. In the most severe cases, the kidneys begin to deteriorate and ultimately fail. One-half of the patients in this toxic phase die within the first ten to fourteen days. The other patients recover, typically without any significant organ damage.

Scientists before Theiler had relied on monkeys as the host for yellow fever. This was not only costly, but also quite dangerous. Monkey-to-human transmission of the virus was possible - as had been confirmed by the tragic death of Adrian Stokes, the researcher who first isolated the virus. Theiler decided there had to be a better way. Though others had tried and failed to use mice for yellow fever research, Theiler made it work. He discovered that the virus needed to be injected directly into the mice's brains, instead of into their abdomens. This was a major breakthrough, allowing for a safer and much quicker research cycle.

Theiler also found that the mice injected with the virus developed encephalitis, a swelling of the brain - that got more acute with each successive culture, but with each pass through mice, the same virus had less of an impact on monkeys. This led Theiler to believe he could develop an "attenuated" vaccine - a vaccine in which the virus has been weakened to the point it will not cause damage, but will still produce an immune response. Others heard of Theiler's results, and he was invited to join the Rockefeller Foundation's Yellow Fever Laboratory (YFL) of Wilbur A. Sawyer. At YFL he discovered he could use chicken embryos to culture the virus. After completing 176 passes of the virus through chick embryos, Theiler tested the vaccine on two monkeys, both of whom survived and developed immunity to the yellow fever virus. Then, in a practice with a long tradition, he tested it on himself, to ensure it was safe. This was it! He named the vaccine 17-D and the vaccine quickly became available for distribution worldwide. Theiler was awarded the 1951 Nobel Prize in Physiology or Medicine for his efforts.

The success of Theiler's vaccine was stunning. With funding from the Rockefeller Foundation, over 28 million doses of the 17D vaccine were distributed between 1940 and 1947. The program was discontinued in 1949 due to the effective eradication of yellow fever as a major disease. Unfortunately, yellow fever continues to be a problem in developing nations in Africa and South America. The World Health Organization estimates there are 200,000 new cases each year, resulting in 30,000 deaths.
readitIntroBelow

readitSeeTally

Introduction by Tim Anderson


Bookcoverjacket


Table of Contents

Introduction
Links to More Information About the Scientist
Key Insight
Key Experiment or Research
Quotes by the Scientist
Quotes About the Scientist
Anecdotes
Fun Trivia About The Science
The Science Behind the Discovery
Personal Information
Key Contributing Scientists
Science Discovery Timeline
Recommended Books About the Science
Books by the Scientist
Books About the Scientist
Awards
Major Academic Papers
Curriculum Vitae
Links to Science and Related Information on the Subject
Sources

 








Links to More About the Scientist & the Science

Nobelprize.org biography:
http://nobelprize.org/nobel_prizes/medicine/laureates/1951/theiler-bio.html

faqs.org biography:
http://www.faqs.org/health/bios/54/Max-Theiler.html

Wikipedia entry:
http://en.wikipedia.org/wiki/Max_Theiler




Sliders & Images here




Image Flow Here




Key Insight




Key Experiments or Research




Quotes by the Scientist




Quotes About the Scientist




Anecdotes




Fun Trivia About the Science




The Science Behind the Discovery



Personal Information




Key Contributing Scientists to the Discovery




Scientific Discovery Timeline




Recommended Books About the Science




Books by the Scientist




Books About the Scientist

 



Awards




Major Academic Papers Written by the Scientist



Curriculum Vitae



Links to Information on the Science





Sources/References